scholarly journals The effect of attenuating dietary phosphate restriction on blood ionized calcium concentrations in cats with chronic kidney disease and ionized hypercalcemia

2021 ◽  
Vol 35 (2) ◽  
pp. 997-1007 ◽  
Author(s):  
Rebecca F. Geddes ◽  
D. Hendrik N. Broek ◽  
Yu‐Mei Chang ◽  
Vincent Biourge ◽  
Jonathan Elliott ◽  
...  
2019 ◽  
pp. 2-3

Impaired phosphate excretion by the kidney leads to Hyperphosphatemia. It is an independent predictor of cardiovascular disease and mortality in patients with advanced chronic kidney disease (stage 4 and 5) particularly in case of dialysis. Phosphate retention develops early in chronic kidney disease (CKD) due to the reduction in the filtered phosphate load. Overt hyperphosphatemia develops when the estimated glomerular filtration rate (eGFR) falls below 25 to 40 mL/min/1.73 m2. Hyperphosphatemia is typically managed with oral phosphate binders in conjunction with dietary phosphate restriction. These drugs aim to decrease serum phosphate by binding ingested phosphorus in the gastrointestinal tract and its transformation to non-absorbable complexes [1].


PLoS ONE ◽  
2013 ◽  
Vol 8 (11) ◽  
pp. e79721 ◽  
Author(s):  
Juliana C. Ferreira ◽  
Guaraciaba O. Ferrari ◽  
Katia R. Neves ◽  
Raquel T. Cavallari ◽  
Wagner V. Dominguez ◽  
...  

Author(s):  
Marguerite Conley ◽  
Katrina L. Campbell ◽  
Carmel M. Hawley ◽  
Nicole M. Lioufas ◽  
Grahame J. Elder ◽  
...  

2019 ◽  
Vol 4 (7) ◽  
pp. S100
Author(s):  
M. Conley ◽  
N.D. Toussaint ◽  
E. Pedagogos ◽  
N. Lioufas ◽  
G.J. Elder ◽  
...  

Author(s):  
Marguerite Conley ◽  
Nicole Lioufas ◽  
Nigel D. Toussaint ◽  
Grahame J. Elder ◽  
Sunil V. Badve ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document